Bayer Steps Up Skin Microbiome Research For Cosmetics With Partner Azitra

 
• By Tom Gallen

Bayer invests $8m in medical dermatology specialist Azitra to advance development of OTC and cosmetic products harnessing the skin microbiome.

3D illustration of spherical and rod-shaped bacteria on skin with hairs, microscopic view of skin microflora, bacteria Staphylococcus, Streptococcus, Propionibacterium on skin
• Source: Shutterstock

More from Deals

More from Business